Finlay Vaccine Institute : Articles

Cuba’s anti-COVID-19 vaccine candidate, Soberana 02 of the Finlay Vaccine Institute (IFV), showed 91.2% efficacy with a third booster shot of Soberana Plus during the third phase of clinical trials. Photo: Endrys Correa Vaillant

Cuba’s Soberana 02 Vaccine Shows 91.2% Efficacy Against COVID-19

Peoples Dispatch

"In name of Cuba, congratulations," said Miguel Díaz-Canel to the researchers of CIGB that worked to create Abdala, the anti-COVID-19 vaccine. Photo: Granma

Cuba’s Abdala and Soberana 02 Vaccines Near the Finish Line

Peoples Dispatch

Cuba Working on a ‘People’s Vaccine’: the US and the World Should get Behind it

Beth Geglia

Cuba Vaccine

Cuba Is One Step Closer to Launching its Own Anti-COVID Vaccines

Tanya Wadhwa